bluebird bio Statistics Share Statistics bluebird bio has 9.79M
shares outstanding. The number of shares has increased by 1%
in one year.
Shares Outstanding 9.79M Shares Change (YoY) 1% Shares Change (QoQ) 0.53% Owned by Institutions (%) 35.91% Shares Floating 9.73M Failed to Deliver (FTD) Shares 466,736 FTD / Avg. Volume 80.99%
Short Selling Information The latest short interest is 499.55K, so 0% of the outstanding
shares have been sold short.
Short Interest 499.55K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.34 and the forward
PE ratio is -0.58.
bluebird bio's PEG ratio is
0.
PE Ratio -0.34 Forward PE -0.58 PS Ratio 0.96 Forward PS 0.1 PB Ratio -2.56 P/FCF Ratio -0.31 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for bluebird bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.48,
with a Debt / Equity ratio of -11.36.
Current Ratio 0.48 Quick Ratio 0.28 Debt / Equity -11.36 Debt / EBITDA -2.28 Debt / FCF -1.36 Interest Coverage -11.98
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $337.93K Profits Per Employee $-970.63K Employee Count 248 Asset Turnover 0.18 Inventory Turnover 1.37
Taxes Income Tax 70K Effective Tax Rate -0.03%
Stock Price Statistics The stock price has increased by -74.73% in the
last 52 weeks. The beta is 0.36, so bluebird bio's
price volatility has been higher than the market average.
Beta 0.36 52-Week Price Change -74.73% 50-Day Moving Average 4.42 200-Day Moving Average 7.51 Relative Strength Index (RSI) 62.84 Average Volume (20 Days) 576,322
Income Statement In the last 12 months, bluebird bio had revenue of 83.81M
and earned -240.72M
in profits. Earnings per share was -24.84.
Revenue 83.81M Gross Profit -5.57M Operating Income -270.46M Net Income -240.72M EBITDA -156.82M EBIT -218.07M Earnings Per Share (EPS) -24.84
Full Income Statement Balance Sheet The company has 62.3M in cash and 358.24M in
debt, giving a net cash position of -295.93M.
Cash & Cash Equivalents 62.3M Total Debt 358.24M Net Cash -295.93M Retained Earnings -4.5B Total Assets 295.96M Working Capital -140.55M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -260.02M
and capital expenditures -2.6M, giving a free cash flow of -262.62M.
Operating Cash Flow -260.02M Capital Expenditures -2.6M Free Cash Flow -262.62M FCF Per Share -27.1
Full Cash Flow Statement Margins Gross margin is -6.65%, with operating and profit margins of -322.72% and -287.23%.
Gross Margin -6.65% Operating Margin -322.72% Pretax Margin -287.14% Profit Margin -287.23% EBITDA Margin -187.12% EBIT Margin -322.72% FCF Margin -313.36%
Dividends & Yields BLUE does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for BLUE is $10,
which is 101.2% higher than the current price. The consensus rating is "Hold".
Price Target $10 Price Target Difference 101.2% Analyst Consensus Hold Analyst Count 7
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 13, 2024. It was a
backward
split with a ratio of 1:20.
Last Split Date Dec 13, 2024 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -23.56 Piotroski F-Score 3
